Sandler Alan B.
SEC insider (Form 3/4/5 filer). CIK 0001835966. Chief Development Officer at Revolution Medicines, Inc. (RVMD) and 2 other issuers. 16 reported Form 4/5 transactions since Sep 2024; latest on Sep 29, 2026. Located in REDWOOD CITY, CA.
Companies Sandler Alan B. has filed insider reports for
- Revolution Medicines, Inc. (RVMD): Officer, Chief Development Officer
- ALX ONCOLOGY HOLDINGS INC (ALXO): Director
- Elevation Oncology, Inc. (ELEV): Director
Sandler Alan B.
CIK: 0001835966
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Sep 29, 2026RVMD
Revolution Medicines, Inc.
SaleDirect301 shares at avg. $204.72$62K - Sep 29, 2026RVMD
Revolution Medicines, Inc.
SaleDirect1K shares at avg. $202.81$203K - Sep 29, 2026RVMD
Revolution Medicines, Inc.
SaleDirect1.2K shares at avg. $203.91$244K - Sep 29, 2026RVMD
Revolution Medicines, Inc.
ExerciseDirect6K shares at avg. $58.84$353K - Sep 29, 2026RVMD
Revolution Medicines, Inc.
SaleDirect2.2K shares at avg. $200.82$442K - Sep 29, 2026RVMD
Revolution Medicines, Inc.
SaleDirect1.6K shares at avg. $201.72$325K - Sep 16, 2026RVMD
Revolution Medicines, Inc.
SaleDirect336 shares at avg. $199.30$67K - Sep 16, 2026RVMD
Revolution Medicines, Inc.
SaleDirect5 shares at avg. $194.96$974.795 - Jan 20, 2026ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectStock option (right to buy)
10.1K shares- - Jul 23, 2025ELEV
Elevation Oncology, Inc.
DispositionDirectStock Option (Right to Buy)
35K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 29, 2026 |  RVMD Revolution Medicines, Inc. | Sale | 301 | $204.72 | $61,621 | Direct |
| Sep 29, 2026 | RVMD Revolution Medicines, Inc. | Sale | 1,000 | $202.81 | $202,813 | Direct |
| Sep 29, 2026 | RVMD Revolution Medicines, Inc. | Sale | 1,199 | $203.91 | $244,485 | Direct |
| Sep 29, 2026 | RVMD Revolution Medicines, Inc. | Exercise | 6,000 | $58.84 | $353,040 | Direct |
| Sep 29, 2026 | RVMD Revolution Medicines, Inc. | Sale | 2,200 | $200.82 | $441,801 | Direct |
| Sep 29, 2026 | RVMD Revolution Medicines, Inc. | Sale | 1,609 | $201.72 | $324,574 | Direct |
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | Sale | 336 | $199.30 | $66,966 | Direct |
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | Sale | 5 | $194.96 | $975 | Direct |
| Jan 20, 2026 |  ALXO ALX ONCOLOGY HOLDINGS INC | Award Stock option (right to buy) | 10,100 | - | - | Direct |
| Jul 23, 2025 |  ELEV Elevation Oncology, Inc. | Disposition Stock Option (Right to Buy) | 35,000 | - | - | Direct |
1-10 of 16 transactions